Is Twist Bioscience Corp (TWST) overvalued? · $5.16B cap
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
This page asks whether Twist Bioscience Corp (TWST) looks expensive on cached numbers — not a short thesis.
No cached income statement for TWST, so there is no earnings base to call rich or cheap.
TWST currently screens at market cap $5.16B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TWST 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TWST stock page for the full model, not this heading.
Not investment advice.